Amra Grudic-Feta's picture

Amra Grudic-Feta

Senior Adviser, Research adviser
  • E-mailAmra.Grudic@uib.no
  • Phone+47 55 97 46 71+47 996 36 904
  • Visitor Address
    8.etg. heis øst
    5021 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

Support towards various funding sources such as Research Council of Norway, EU Horizon2020, Norwegian Cancer Society, Bergen Research Foundation (BFS), and others

Assistance to the researchers during the application writing process

Mobilization towards relevant calls

Career advising

Strategy development



Academic article
  • Show author(s) (2018). Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. International Journal of Cancer. 1735-1745.
  • Show author(s) (2013). The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro-Oncology. 269-278.
  • Show author(s) (2012). The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling. Blood. 847-857.
  • Show author(s) (2010). Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein. BMC Molecular Biology. 12 pages.
  • Show author(s) (2009). Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins. Journal of Cell Science. 1201-1210.
  • Show author(s) (2007). Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres. Nucleic Acids Research (NAR). 7267-7278.
  • Show author(s) (2006). Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. Journal of Cell Science. 3284-3295.
Masters thesis
  • Show author(s) (2010). The Expression and Localization of Id1 and Id3 in Glioblastoma Multiforme.
  • Show author(s) (2005). Characterization of a functional interplay between promyelocytic leukemia protein & replication protein A.
Doctoral dissertation
  • Show author(s) (2012). Promyelocytic leukemia bodies – functions and dynamics.
  • Show author(s) (2010). APPLICATION OF A NOVEL P53 REPORTER ASSAY IN HUMAN GLIOBLASTOMA CELLS. Neuro-Oncology. 96-96.

More information in national current research information system (CRIStin)